NCT03744793: Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 18 taking part
- Started
- 11 Apr 2019
- Primary completion
- 31 Jan 2027
- Arms
- Treatment (pemetrexed, avelumab)
- Results
- None posted
- 16 Nov 2018: Trial registered
- 11 Apr 2019: Trial started